Article Information
vol. 8 no. 1
Published By
Online ISSN
History
- Received June 10, 2021
- Accepted September 27, 2021
- Published online March 28, 2022.
Article Versions
- previous version (December 23, 2021 - 07:25).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright ©The authors 2022 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org
Author Information
- Stefano Aliberti1,2,10⇑,
- Francesco Amati1,2,10,
- Andrea Gramegna3,4,
- Barbara Vigone5,
- Martina Oriano3,4,
- Giovanni Sotgiu6,
- Marco Mantero3,4,
- Edoardo Simonetta3,4,
- Laura Saderi6,
- Anna Stainer1,2,
- Serena Tammaro3,
- Paola Marchisio4,7,
- Eva Polverino8,
- James D. Chalmers9 and
- Francesco Blasi3,4
- 1Dept of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy
- 2IRCCS Humanitas Research Hospital, Respiratory Unit, Rozzano, Italy
- 3Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Respiratory Unit and Cystic Fibrosis Adult Center, Milan, Italy
- 4Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
- 5Scleroderma Unit, Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
- 6Clinical Epidemiology and Medical Statistics Unit, Dept of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy
- 7Pediatric Highly Intensive Care Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
- 8Pneumology Dept, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca, Barcelona, Spain
- 9College of Medicine, University of Dundee, Dundee, UK
- 10These authors contributed equally
- )Corresponding author: Stefano Aliberti (stefano.aliberti{at}hunimed.eu
Funding
Takeda Pharmaceutical Company
9891332
Article usage
Altmetrics
Vol 8 Issue 1
Table of Contents
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients
